Department of Chemistry, University of Cape Town, Rondebosch, 7701, South Africa.
Malar J. 2011 Mar 15;10 Suppl 1(Suppl 1):S2. doi: 10.1186/1475-2875-10-S1-S2.
Malaria continues to be an enormous global health challenge, with millions of new infections and deaths reported annually. This is partly due to the development of resistance by the malaria parasite to the majority of established anti-malarial drugs, a situation that continues to hamper attempts at controlling the disease. This has spurred intensive drug discovery endeavours geared towards identifying novel, highly active anti-malarial drugs, and the identification of quality leads from natural sources would greatly augment these efforts. The current reality is that other than compounds that have their foundation in historic natural products, there are no other compounds in drug discovery as part of lead optimization projects and preclinical development or further that have originated from a natural product start-point in recent years. This paper briefly presents both classical as well as some more modern, but underutilized, approaches that have been applied outside the field of malaria, and which could be considered in enhancing the potential of natural products to provide or inspire the development of anti-malarial lead compounds.
疟疾仍然是一个巨大的全球健康挑战,每年都有数百万人感染并因此死亡。这在一定程度上是由于疟原虫对大多数已建立的抗疟药物产生了耐药性,这种情况继续阻碍了对该疾病的控制尝试。这促使人们进行了密集的药物发现工作,旨在寻找新型、高度有效的抗疟药物,而从天然来源中确定质量先导化合物将极大地增强这些努力。目前的现实情况是,除了以历史天然产物为基础的化合物外,在药物发现中,没有其他化合物作为先导优化项目和临床前开发的一部分,或者近年来没有其他化合物源自天然产物起点。本文简要介绍了除疟疾领域外应用的一些经典的、以及一些更现代的但未充分利用的方法,这些方法可以考虑用于增强天然产物提供或启发抗疟先导化合物开发的潜力。